The Center for Connected Medicine (CCM) has released its third annual Top of Mind for Top Health Systems report with insights on technology priorities from a survey of health system leaders.
The report focuses on three technology areas that are essential for the transition to value-based care: patient engagement, data aggregation and analytics, and precision medicine. To varying degrees health systems are pursuing solutions in these areas but find that limited resources and lack of reimbursement remain significant barriers to adoption, according to Top of Mind findings.
“Health systems are moving toward a risk-based world where they will have a bigger financial stake in better managing the health of their patients. Having access to complete patient data and analyzing it, keeping patients engaged in their health, and delivering more effective treatments are essential to managing risk,” said Pamela Peele, Ph.D., chief analytics officer of UPMC Health Plan and UPMC Enterprises.
“Finding the money to deploy these important technologies, while managing the other financial pressures health systems face, is a challenge for all health care providers,” continued Peele, who is a member of the steering committee for the CCM, which is jointly operated by GE Healthcare, Nokia and UPMC.
While many patients expect a digital experience in health care that’s on par with what they have in other, more technologically advanced industries, health systems reported low adoption. Respondents said that, on average, 35% of patients have adopted engagement technologies that are available to them.
The ability to aggregate and analyze data from multiple sources is essential for health systems that want to produce better outcomes and reduce costs. And while respondents reported having 71% of data from clinical sources integrated, on average, they also said limited resources, lack of data standards, and poor data normalization were the greatest barriers to complete data aggregation.
With its potential to improve clinical outcomes, precision medicine is a growing area of interest for health systems. However, high barriers to entry and uncertain funding models so far have limited adoption. Nearly 70% of interviewed organizations report low maturity or no deployment of precision medicine efforts.
Conducted in partnership with KLAS Research, the Top of Mind survey collected responses from 70 leaders at 65 health systems. Nearly half the respondents were chief information officers.
A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
Werewolf Therapeutics launches as publicly traded company
Werewolf Therapeutics, a biopharmaceutical company pioneering the development of therapeutics to stimulate the body’s immune …
The Intersection of Value and AI: Where Machines Can Make a Difference
Upcoming CCM panel discussion features experts from UPMC, Vanderbilt, NCQA, and Astrata on the future of artificial intelligence in health care